MDCO’s CC re in-licensing of PFE’s ApoA1 Milano was notable in that MDCO’s executives could be heard openly laughing at some of the CC questions. Worth a listen, IMO, for entertainment value as well as investment value. Webcast link: http://ir.themedicinescompany.com/phoenix.zhtml?c=122204&p=irol-EventDetails&EventId=2623623 Slides: http://www.themedicinescompany.com/pdf/MDCO%20-%20ApoA-I%20Milano%20Acquisition.pdf